Deregulation of IRF Menbers in Human Retroviral Infection
Deregulation of IRF Menbers in Human Retroviral Infection
批准号:
08044259
负责人:
MATSUYAMA Toshifumi
金额:
$4.67万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this study, we focused on the role of Interferon Regulatory Factor ( IRF ) family members in retroviral infection. First we could demonstrate the essential role of LSIRF/IRF-4, an IRF member solely expressed in mature lymphocytes, in T and B function by the development of the gene targeted mouse. In this mutant mouse, the number of T and B lymphocytes is normal, but disable to mount proliferative responses against mitogens or anti-CD3 antibodies or alloantigens. In human, constitutive expression of LSIRF/lRF-4 is found only in cells infected with HTLV-1 , a causative agent of adult leukemia/lymphoma which is prevalent in our Nagasaki area. From clinical analysis, high-expression level is well correlated with the leukemic stage of the patients of ATL, suggesting the possible marker for prognosis in the disease as well as the role of the factor in leukemia as an oncogene. However, many efforts to clone a stable transformant with ectopically expressed LSIRF/lRF-4 is unsuccessful. Developing an inducible expression system of LSIRF/lRF-4, and isolating its associated factor (s) by yeast two-hybrid systems are now in progress.In case of IRF-1 deficient mouse, poor development of NK cells and low expression of IL-1 5 was found. The latter caused by the defect of IRF-1 expression, at least in part, seems to contribute to the impairment of NK cells development. It is interesting to seek physiological conditions of low expression of IRF-1 , by which individuals are susceptible to viral infection in general. On the other hand, this mutant mouse is resistant to a experimental model of human multiple sclerosis, a disease suggestedly caused by retroviral infection, implying that individuals protect themselves against retroviral infection by induction of IRF-1 at the risk of some autoimmune disease involvement.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Mittrucker H. W., et al: "Requirement for the transcription factor LSIRF/IRF-4 for mature B and T lymphocyte function." Science. 275. 540-543 (1997)
Mittrucker H. W. 等人:“成熟 B 和 T 淋巴细胞功能需要转录因子 LSIRF/IRF-4。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tada Y., et al: "Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking IRF-1" J. Exp. Med.185. 231-238 (1997)
Tada Y. 等人:“缺乏 IRF-1 的小鼠中抗原诱导的自身免疫性疾病的发生率和严重程度降低”J. Exp。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka N., et al.: "Cooperation of the tumor suppressors IRF-1 and p53 in response to DNA damage" Nature. 382. 816-818 (1996)
Tanaka N. 等人:“肿瘤抑制因子 IRF-1 和 p53 响应 DNA 损伤的合作”Nature。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mittrucker H.W: "Requirement for the transcription factor LSIRF/IRF-4 for mature B and T lymphocyte function." Science. 275. 540-543 (1997)
Mittrucker H.W:“成熟 B 和 T 淋巴细胞功能需要转录因子 LSIRF/IRF-4。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tada Y, et al.: "Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking IRF-1"J. Exp. Med.. 185. 231-238 (1997)
Tada Y 等人:“缺乏 IRF-1 的小鼠中抗原诱导的自身免疫性疾病的发生率和严重程度降低”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
Establishment of an interferon transfer factor prevention cell strainuseful on virus hunting
-
批准号:22659092
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.97万
-
财政年份:2010
-
负责人:MATSUYAMA Toshifumi
-
依托单位:
Analysis of the acute pancreatitis in the mice deficient for the IRF-2 gene
-
批准号:18390124
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.55万
-
财政年份:2006
-
负责人:MATSUYAMA Toshifumi
-
依托单位:
Role of IRF-4 in adult T cell Leukemia/lymphoma
-
批准号:15390117
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.67万
-
财政年份:2003
-
负责人:MATSUYAMA Toshifumi
-
依托单位:
Molecular mechanism of acute pancreatitis provoked by double-stranded RNA
-
批准号:13670530
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:MATSUYAMA Toshifumi
-
依托单位:
Role of IFN transcription factors, IRF-1, and IRF-2 in acute hepatic injury model
-
批准号:10470060
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.46万
-
财政年份:1998
-
负责人:MATSUYAMA Toshifumi
-
依托单位:
国内基金
海外基金
系统性探索不同N-glycan修饰对Interferonβ活性和稳定性影响
-
批准号:21877063
-
项目类别:面上项目
-
资助金额:61.4万元
-
批准年份:2018
-
负责人:王鹏
-
依托单位:
糖药物蛋白Interferonβ N-glycan的均一、人源化改造
-
批准号:81102361
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:程剑松
-
依托单位: